• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部用环孢素治疗盾形溃疡

Topical cyclosporine in the management of shield ulcers.

作者信息

Cetinkaya Altug, Akova Yonca Aydin, Dursun Dilek, Pelit Aysel

机构信息

Department of Ophthalmology, Baskent University Faculty of Medicine, Ankara, Turkey.

出版信息

Cornea. 2004 Mar;23(2):194-200. doi: 10.1097/00003226-200403000-00014.

DOI:10.1097/00003226-200403000-00014
PMID:15075890
Abstract

PURPOSE

To report our experience with 0.05%-2% topical cyclosporine in the treatment of 4 cases of severe, corticosteroid-resistant, vernal keratoconjunctivitis with shield ulcers.

METHODS

Four patients with shield ulcers not responding to medical treatment with topical steroids, antihistamines, and mast-cell stabilizers were treated with 0.05%-2% topical cyclosporine. The frequency of application was 4 times daily in all cases, and the concentration was adjusted according to the clinical status starting with 2%.

RESULTS

Healing of ulcers with no epithelial defect occurred in 10 days with the 2% concentration in all cases. The patients experienced no side effects except for a burning sensation during administration. Recurrences occurred when the concentration was decreased to 0.05% in 3 cases. The recurrences were effectively treated with 1% concentration in all cases, and patients were stable with this concentration for at least 6 months.

CONCLUSIONS

Topical cyclosporine is an effective treatment alternative in the management of shield ulcers in patients with vernal keratoconjunctivitis. The 1% concentration seems to be the minimal effective concentration in such cases in our experience, but further controlled studies are needed to support our findings.

摘要

目的

报告我们使用0.05%-2%的局部用环孢素治疗4例伴有盾形溃疡的重度、糖皮质激素抵抗性春季角结膜炎的经验。

方法

4例对局部用类固醇、抗组胺药和肥大细胞稳定剂治疗无效的盾形溃疡患者接受了0.05%-2%的局部用环孢素治疗。所有病例的用药频率均为每日4次,并根据临床状况从2%开始调整浓度。

结果

所有病例使用2%浓度时,溃疡在10天内愈合且无上皮缺损。患者除用药期间有烧灼感外无其他副作用。3例患者在浓度降至0.05%时出现复发。所有病例使用1%浓度均有效治疗了复发情况,且患者在该浓度下至少稳定6个月。

结论

局部用环孢素是治疗春季角结膜炎患者盾形溃疡的一种有效替代疗法。根据我们的经验,1%浓度似乎是此类病例中的最低有效浓度,但需要进一步的对照研究来支持我们的发现。

相似文献

1
Topical cyclosporine in the management of shield ulcers.局部用环孢素治疗盾形溃疡
Cornea. 2004 Mar;23(2):194-200. doi: 10.1097/00003226-200403000-00014.
2
Management of severe allergic conjunctivitis with topical cyclosporin a 0.05% eyedrops.使用0.05%环孢素A滴眼液治疗重度过敏性结膜炎。
Cornea. 2007 Oct;26(9):1035-8. doi: 10.1097/ICO.0b013e31812dfab3.
3
Vernal shield ulcers treated with frequently installed topical cyclosporine 0.05% eyedrops.使用频繁安装的0.05%环孢素滴眼液治疗春季角结膜炎性盾形溃疡。
Int Ophthalmol. 2018 Feb;38(1):363-368. doi: 10.1007/s10792-016-0424-z. Epub 2017 Jan 24.
4
Combined therapy for vernal shield ulcer.春季角结膜炎性溃疡的联合治疗
Clin Exp Optom. 2008 Jan;91(1):111-4. doi: 10.1111/j.1444-0938.2007.00183.x.
5
An immunohistochemical study of topical cyclosporine in vernal keratoconjunctivitis.
Am J Ophthalmol. 1996 Feb;121(2):156-61. doi: 10.1016/s0002-9394(14)70579-3.
6
Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis.环孢素滴眼液治疗儿童春季角结膜炎 156 例的长期安全性和疗效。
Int J Immunopathol Pharmacol. 2010 Jul-Sep;23(3):865-71. doi: 10.1177/039463201002300322.
7
A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.一项关于新型0.1%环孢素眼药水治疗重度过敏性结膜炎的大型前瞻性观察性研究。
J Ocul Pharmacol Ther. 2009 Aug;25(4):365-72. doi: 10.1089/jop.2008.0103.
8
Topical cyclosporin A in the management of vernal keratoconjunctivitis.局部应用环孢素A治疗春季角结膜炎
Eye (Lond). 2001 Feb;15(Pt 1):39-41. doi: 10.1038/eye.2001.10.
9
Surgical debridement plus topical cyclosporine A in the treatment of vernal shield ulcers.手术清创联合环孢素 A 局部治疗春季角结膜炎性溃疡。
Int J Immunopathol Pharmacol. 2012 Jul-Sep;25(3):775-80. doi: 10.1177/039463201202500326.
10
Vernal Keratoconjunctivitis: A Systematic Review.春季角结膜炎:系统评价。
Clin Rev Allergy Immunol. 2023 Aug;65(2):277-329. doi: 10.1007/s12016-023-08970-4. Epub 2023 Sep 2.

引用本文的文献

1
Application of topical 2% cyclosporine A in inflammatory ocular surface diseases.局部应用 2%环孢素 A 治疗炎症性眼表疾病。
Int Ophthalmol. 2023 Nov;43(11):3943-3952. doi: 10.1007/s10792-023-02796-x. Epub 2023 Jul 7.
2
Management of vernal keratoconjunctivitis in children in Saudi Arabia.沙特阿拉伯儿童春季角结膜炎的管理
Oman J Ophthalmol. 2020 Feb 17;13(1):3-12. doi: 10.4103/ojo.OJO_263_2018. eCollection 2020 Jan-Apr.
3
Vernal shield ulcers treated with frequently installed topical cyclosporine 0.05% eyedrops.使用频繁安装的0.05%环孢素滴眼液治疗春季角结膜炎性盾形溃疡。
Int Ophthalmol. 2018 Feb;38(1):363-368. doi: 10.1007/s10792-016-0424-z. Epub 2017 Jan 24.
4
Effect of 0.05% topical cyclosporine for the treatment of symptomatic subepithelial infiltrates due to adenoviral keratoconjunctivitis.0.05%局部用环孢素治疗腺病毒性角结膜炎所致症状性上皮下浸润的效果。
Int J Ophthalmol. 2016 Apr 18;9(4):634-5. doi: 10.18240/ijo.2016.04.26. eCollection 2016.
5
Management of vernal keratoconjunctivitis.春季角结膜炎的治疗。
Ophthalmol Ther. 2013 Dec;2(2):73-88. doi: 10.1007/s40123-013-0019-y. Epub 2013 Sep 7.
6
Modern approach to managing vernal keratoconjunctivitis.现代方法治疗春季角结膜炎。
Curr Allergy Asthma Rep. 2010 May;10(3):155-62. doi: 10.1007/s11882-010-0101-7.
7
Ocular allergy in pediatric practice.儿科临床中的眼部过敏
Curr Allergy Asthma Rep. 2006 Jul;6(4):306-11. doi: 10.1007/s11882-006-0064-x.
8
Topical ciclosporin in the treatment of ocular surface disorders.局部用环孢素治疗眼表疾病。
Br J Ophthalmol. 2005 Oct;89(10):1363-7. doi: 10.1136/bjo.2005.070888.
9
[Ocular allergies].[眼部过敏]
Ophthalmologe. 2005 May;102(5):527-43; quiz 544. doi: 10.1007/s00347-005-1181-y.